Lipid-based formulations and versatile liquid-filled hard capsule (LFHC) technology are core strengths of Lonza. LFHC technology has a proven track record in addressing a range of complex formulation challenges inclusive of solubility/bioavailability and low dose/highly potent API issues. We provide integrated services for LFHC development and manufacturing from proof-of-concept studies through clinical trial manufacture and commercialization.
Liquid-filled hard capsule technology provides an advanced dosage form for liquid and semi-solid formulations. LFHC technology has been utilized in bringing new molecules to market and repositioning existing molecules for improved performance or new indications. Our product development teams utilize LFHC across a range of applications, which result in innovative dosage forms that are leak-proof, airtight, and impermeable to moisture, oxygen and light.